Home / Recalls / Leading Pharma, LLC / D-1546-2022

D-1546-2022 Class III Terminated

Recalled by Leading Pharma, LLC — Fairfield, NJ

Recall Details

Product Type: Drugs
Report Date: October 5, 2022
Initiation Date: August 23, 2022
Termination Date: September 28, 2023
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 960 bottles (100 capsules)

Product Description

ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01

Reason for Recall

Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules

Distribution Pattern

Nationwide within the United States

Code Information

Lot#: B14221, Exp. Date 02/2023